UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000037527
Receipt number R000042779
Scientific Title Investigational research of gut microbiome associated with hypertensive patients
Date of disclosure of the study information 2019/09/30
Last modified on 2023/01/30 10:24:45

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

Investigational research of gut microbiome associated with hypertensive patients

Acronym

GMH

Scientific Title

Investigational research of gut microbiome associated with hypertensive patients

Scientific Title:Acronym

GMH

Region

Japan


Condition

Condition

Hypertension

Classification by specialty

Medicine in general Cardiology

Classification by malignancy

Others

Genomic information

NO


Objectives

Narrative objectives1

Reveal intestinal flora specific to hypertensive patients

Basic objectives2

Others

Basic objectives -Others

To clarify the difference of intestinal flora due to obesity and salt intake

Trial characteristics_1

Exploratory

Trial characteristics_2

Others

Developmental phase

Not applicable


Assessment

Primary outcomes

Comparison of intestinal flora of control group (concurrently, non-hypertensive person) and hypertensive patient

Key secondary outcomes

Comparison of intestinal flora with obesity and salt intake


Base

Study type

Interventional


Study design

Basic design

Single arm

Randomization

Non-randomized

Randomization unit


Blinding

Open -no one is blinded

Control

Uncontrolled

Stratification

NO

Dynamic allocation

NO

Institution consideration


Blocking

NO

Concealment



Intervention

No. of arms

1

Purpose of intervention

Educational,Counseling,Training

Type of intervention

Behavior,custom

Interventions/Control_1

Nutrition instruction

Interventions/Control_2


Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

20 years-old <=

Age-upper limit

70 years-old >

Gender

Male and Female

Key inclusion criteria

high blood pressure (office systolic blood pressure more than 140 or/and diastolic blood pressure more than 90 mmHg or taking antihypertensive drugs)

Key exclusion criteria

Patients who are pregnant or nursing
Person who meets overt diabetes (fasting blood glucose 126 mg / dl or more, blood glucose 200 mg / dl or more, HbA1c 6.5% or more, or taking antidiabetic medication)
Person with severe organ damages (cerebral infarction, cerebral hemorrhage, chronic kidney disease stage 4 or more: eGFR <30, heart failure etc)
Those who participate in other clinical research

Target sample size

300


Research contact person

Name of lead principal investigator

1st name Arakawa
Middle name
Last name Kimika

Organization

National Hospital Organization Kyushu Medical Center

Division name

Department of Clinical Laboratory

Zip code

8108563

Address

1-8-1 Jigyohama, Chuo-ku, Fukuoka, Japan

TEL

092-852-0700

Email

arakawa.kimika.rp@mail.hosp.go.jp


Public contact

Name of contact person

1st name Kimika
Middle name
Last name Arakawa

Organization

National Hospital Organization Kyushu Medical Center

Division name

Department of Clinical Laboratory

Zip code

8108563

Address

1-8-1 Jigyohama, Chuo-ku, Fukuoka, Japan

TEL

092-852-0700

Homepage URL


Email

arakawa.kimika.rp@mail.hosp.go.jp


Sponsor or person

Institute

National Hospital Organization Kyushu Medical Center, Department of Clinical Laboratory

Institute

Department

Personal name



Funding Source

Organization

Ministry of education

Organization

Division

Category of Funding Organization

Japanese Governmental office

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization

National Hospital Organization Kyushu Medical Center, Clinical trial support center

Address

1-8-1 Jigyohama, Chuo-ku, Fukuoka, Japan

Tel

092-852-0700

Email

602-rinri@mail.hosp.go.jp


Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions



Other administrative information

Date of disclosure of the study information

2019 Year 09 Month 30 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled


Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

No longer recruiting

Date of protocol fixation

2019 Year 07 Month 24 Day

Date of IRB

2019 Year 07 Month 24 Day

Anticipated trial start date

2019 Year 09 Month 15 Day

Last follow-up date

2023 Year 12 Month 31 Day

Date of closure to data entry


Date trial data considered complete


Date analysis concluded



Other

Other related information



Management information

Registered date

2019 Year 07 Month 29 Day

Last modified on

2023 Year 01 Month 30 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000042779


Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name